Share Print

Clinical Study Accrual Monitoring

Clinical studies are crucial to advancing science across the cancer care continuum, from prevention to survivorship. Broad inclusion of diverse people in clinical studies is essential to assuring that emerging cancer care standards for prevention, diagnosis and treatment are equally effective for all sectors of society.

Although federal mandates require sufficient representation of minorities in study samples, there continues to be nationwide disparity in the representation of racial and ethnic minorities and other groups in clinical studies. Factors that contribute to this disparity are well-documented  and complex, including patient factors and broad community and societal factors.

Broad inclusion of diverse people in clinical studies is a priority of the Siteman Cancer Center. PECaD’s Clinical Study Accrual Monitoring/Clinical Studies Outreach (CSO) Program coordinates this effort. Investigators are highlighted in PECaD’s quarterly newsletter.

CSO Program Goals:

  • Increase minority recruitment through active interventions and monitoring
  • Increase minority participation until participation rates mirror the incidence rates for individual cancers
  • Equalize Siteman patient demographics with those of the service region

To meet those goals, PECaD offers a variety of resources for clinical investigators.
To learn more, e-mail PECaD@wudosis.wustl.edu or call 314-747-4611.